Program Schedule

Changing Regimens: Managing the Successful and Drug Resistant Patient

Session: Symposium: HIV State-of-the-Art
Friday, October 10, 2014: 9:00 AM
Room: The Pennsylvania Convention Center: 103-ABC
David Wohl, MD, University of North Carolina, Chapel Hill, NC

David Alain Wohl, MD is an Associate Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina (UNC) with a joint appointment in the Department of Epidemiology at the UNC School of Public Health. He is Site Leader of the UNC AIDS Clinical Trials Unit at Chapel Hill and Co-Directs HIV Services for the North Carolina Department of Corrections. Dr. Wohlís research interests fall into two major areas: the metabolic complications of HIV and its therapies and the nexus between incarceration and the HIV epidemic. He has chaired or co-chaired several AIDS Clinical Trials Group (ACTG) investigations and committees dedicated to understanding the etiology and management of metabolic complications and has led investigator-initiated trials in this area. In addition, Dr. Wohl directs the UNC Center for AIDS Research (CFAR) Prison Working Group, is principal investigator for two National Institute of Drug Abuse (NIDA) funded studies to develop strategies for improved detection and control of HIV infection among current and former prison inmates and directs the UNC BRIGHT Program, a case management organization for HIV-infected prisoners. In addition, Dr. Wohl serves as a member of the Department of Health and Human Services (DHHS) HIV treatment guidelines panel and the National Institutes of Health (NIH) Behavioral and Social Consequences of HIV study review section. He also leads UNCís Clinton Foundation supported China HIV training initiative. In addition to his research and administrative activities, Dr. Wohl maintains a large HIV continuity clinic at UNC.

See more of: HIV State-of-the-Art
See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek